We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Analysis

No Quick Road Ahead For Pa. Risperdal Punitives, Attys Say

Law360, Philadelphia (January 10, 2018, 7:30 PM EST) -- It may seem Johnson & Johnson suffered a major blow after a Pennsylvania appeals court recently put the prospect of punitive damages back on the table in thousands of Risperdal breast-growth cases in Philadelphia, but attorneys say convincing trial judges to greenlight any such awards will be no easy task.

A ruling on Monday struck down a global order that had allowed J&J to avoid punitive damages in some 6,400 Risperdal-related cases under a statute in its native New Jersey, and instead put the onus on...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.